Charles lieber news

Charles Lieber is a prominent American chemist and professor who has been in the news recently due to his involvement in a federal investigation and subsequent charges related to his research funding and activities.

Here are some recent news articles and updates about Charles Lieber:

  1. Federal charges: In January 2020, Lieber was charged with making false statements to the National Institutes of Health (NIH) about his research funding and activities. He was accused of concealing his ties to the Chinese government and failing to disclose his receipt of millions of dollars in funding from the Chinese government.
  2. Research funding: Lieber was a professor at Harvard University and had received millions of dollars in funding from the NIH and other sources for his research on nanotechnology and materials science. However, it was alleged that he had also received funding from the Chinese government and had failed to disclose this funding.
  3. Chinese government ties: Lieber had previously been a visiting professor at the University of Science and Technology of China (USTC) and had received funding from the Chinese government for his research. He was also a member of the Chinese Academy of Sciences.
  4. Investigation: The investigation into Lieber's activities was launched by the FBI and the US Department of Justice. It was alleged that Lieber had lied about his ties to the Chinese government and had failed to disclose his receipt of funding from the Chinese government.
  5. Plea deal: In May 2020, Lieber pleaded guilty to making false statements to the NIH and to concealing his ties to the Chinese government. He faces up to five years in prison and a fine of up to $250,000.
  6. Sentencing: Lieber's sentencing is scheduled for October 2020. He has been released on bail and is subject to electronic monitoring.
  7. Impact on research: The case has raised concerns about the integrity of research funding and the potential for conflicts of interest. It has also highlighted the need for researchers to disclose their funding sources and to avoid conflicts of interest.

Here are some news articles about Charles Lieber: